Leaf Ventures Ii, L.P.New L... Net Worth

The estimated Net Worth of Leaf Ventures Ii, L.P.New L... is at least $10.1 Milión dollars as of 6 May 2013. Leaf L owns over 200,000 units of MEI Pharma Inc stock worth over $6,177,335 and over the last 12 years Leaf sold MEIP stock worth over $3,897,904.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Leaf L MEIP stock SEC Form 4 insiders trading

Leaf has made over 2 trades of the MEI Pharma Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently Leaf sold 200,000 units of MEIP stock worth $1,716,000 on 6 May 2013.

The largest trade Leaf's ever made was selling 257,300 units of MEI Pharma Inc stock on 18 April 2013 worth over $2,181,904. On average, Leaf trades about 228,650 units every 9 days since 2013. As of 6 May 2013 Leaf still owns at least 2,045,475 units of MEI Pharma Inc stock.

You can see the complete history of Leaf L stock trades at the bottom of the page.

Insiders trading at MEI Pharma Inc

Over the last 12 years, insiders at MEI Pharma Inc have traded over $26,282,680 worth of MEI Pharma Inc stock and bought 597,450 units worth $2,541,200 . The most active insiders traders include Ventures Vii, Llc Vivo Vent..., Leaf Ventures Ii, L.P.New L... a Josiah T Austin. On average, MEI Pharma Inc executives and independent directors trade stock every 91 days with the average trade being worth of $360,383. The most recent stock trade was executed by Funds Management Lp Anson A... on 22 September 2023, trading 48,060 units of MEIP stock currently worth $329,211.

What does MEI Pharma Inc do?

mei pharma (nasdaq: meip) is a san diego-based oncology company focused on the clinical development of novel therapies for cancer. our lead drug candidate is pracinostat, a potential best-in-class, oral hdac inhibitor that has been granted breakthrough therapy designation from the fda in combination with azacitidine for the treatment of patients with newly diagnosed aml who are ≥75 years of age or unfit for intensive chemotherapy. our pipeline of drug candidates also includes me-401 (formerly pwt143), a next-generation oral pi3k delta inhibitor, and me-344, a novel mitochondrial inhibitor. for more, please go to www.meipharma.com.

Complete history of Leaf L stock trades at MEI Pharma Inc

MEI Pharma Inc executives and stock owners

MEI Pharma Inc executives and other stock owners filed with the SEC include:

• Daniel Gold,
  President, Chief Executive Officer, Director
• David Urso,
  Chief Operating Officer, General Counsel
• Dr. Daniel P. Gold,
  Pres, CEO & Director
• Brian Drazba,
  Chief Financial Officer, Secretary
• David M. Urso B.A., Esq., J.D.,
  COO & Gen. Counsel
• Robert Mass,
  Chief Medical Officer
• Brian G. Drazba B.A., CPA, CPA,
  CFO & Sec.
• Dr. Richard G. Ghalie,
  Chief Medical Officer
• Dr. Robert D. Mass,
  Strategic Advisor
• Charles Baltic,
  Independent Director
• Nicholas Glover,
  Independent Director
• Kevan Clemens,
  Independent Director
• Frederick Driscoll,
  Independent Director
• Tamar Howson,
  Independent Director
• Cheryl Cohen,
  Director
• Brian Powl,
  Senior Vice President of Marketing
• Tina Clark Beamon Esq., J.D.,
  Chief Compliance Officer
• Dr. Karen E. Potts Ph.D.,
  Sr. VP of Regulatory Affairs
• Dr. Ofir Moreno,
  Sr. VP of Pharmaceutical Sciences
• Jamie A. Tereschuck,
  VP of HR
• David A. Walsey J.D., L.L.M.,
  VP of IR & Corp. Communications
• Leaf Ventures Ii, L.P.New L...,
  
• Ventures V, Llc Vivo,
  
• Leah Rush Cann,
  Director
• Thomas M. Zech,
  Chief Financial Officer
• William Dodge Rueckert,
  Director
• Ventures Vii, Llc Vivo,
  
• Christine Anna White,
  Director
• Ventures V, Llc Vivo Ventur...,
  
• Leaf Ventures Ii, L.P.New L...,
  
• Leaf Ventures Ii, L.P.New L...,
  
• Ventures Vii, Llc Vivo Vent...,
  
• Josiah T El Coronado Holdin...,
  
• Leaf Ventures Ii, L.P.New L...,
  
• Josiah T Austin,
  10% owner
• Bryan Williams,
  Director
• Ltd Novogen,
  10% owner
• Sujay Kango,
  
• Richard G Ghalie,
  Chief Medical Officer
• Thomas C Reynolds,
  
• Funds Management Lp Anson A...,
  
• Funds, Lp Cable Car Capital...,
  
• Steven D Wood,
  
• James P Flynn,